Drug Pricing
Commentary
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Commentary
Governor’s health care proposal puts politics before patients
In California, politics is taking precedence over patients. That’s the only conclusion to draw from Gov. Gavin Newsom’s recently released health care plan. He’s looking to impose price controls on prescription drugs. He’d like to expand Medicaid to undocumented immigrants up to the age of 26. He’s called for re-imposing ...
Commentary
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Business & Economics
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Commentary
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Commentary
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Commentary
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
Commentary
Health spending in US is finally slowing: Here’s why
America’s health bill appears to be moderating, and market forces deserve the credit for this good news. National health expenditures grew more slowly in 2017 than in 2016, according to a report from the Centers for Medicare and Medicaid Services. The CMS statistics break down cost increases by category. Private health insurance spending grew ...
California
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
Commentary
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
The FDA has problems — Here are the qualities the next commissioner must have to fix them
The Food and Drug Administration (FDA) is the nation’s most ubiquitous regulatory agency. It oversees a vast array of medical and food products that account for 25 cents of every consumer dollar, with a value of over a trillion dollars annually. And the agency has problems. It’s too risk-averse, bureaucratically ...
Governor’s health care proposal puts politics before patients
In California, politics is taking precedence over patients. That’s the only conclusion to draw from Gov. Gavin Newsom’s recently released health care plan. He’s looking to impose price controls on prescription drugs. He’d like to expand Medicaid to undocumented immigrants up to the age of 26. He’s called for re-imposing ...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. “Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer, or to our Country!” ...
Progressives’ Prescription Drug Plan Puts Patients At Risk
In mid-January, three Democrats — Vermont Sen. Bernie Sanders, Maryland Rep. Elijah Cummings, and California Rep. Ro Khanna — introduced legislation that aims to reduce prescription drug prices. Their plan would essentially peg U.S. drug prices to those in five foreign countries where prices are typically lower because their governments forcibly control ...
Imposing price controls on prescription drugs
President Donald Trump and Sen. Bernie Sanders don’t agree on much. But they both believe in price controls. Both men recently introduced separate proposals to impose price controls on prescription drugs. Though both men are likely well-intentioned, their plans are deeply misguided. Both proposals would discourage drug research and reduce ...
Health spending in US is finally slowing: Here’s why
America’s health bill appears to be moderating, and market forces deserve the credit for this good news. National health expenditures grew more slowly in 2017 than in 2016, according to a report from the Centers for Medicare and Medicaid Services. The CMS statistics break down cost increases by category. Private health insurance spending grew ...
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
A Market-Based Solution to Rising Drug Prices: More Competition
By Henry I. Miller, M.S., M.D. and John J. Cohrssen President Trump and high-ranking officials in his administration, including Health and Human Services Secretary Alex Azar, Council of Economic Advisers Chairman Kevin Hassett and acting White House chief of staff Mick Mulvaney, are scheduled to meet tomorrow for a strategy ...
